Boston, MA – Strand Therapeutics has announced the appointment of Kunal Bhatia as Chief Financial Officer. About Strand Therapeutics: Strand Therapeutics is a clinical-stage biotechnology company pioneering breakthrough mRNA therapeutics with advanced targeted delivery systems…
Funding will advance Strand’s pipeline and mission to bring targeted, next-generation mRNA therapies to patients First-in-human solid tumor Phase 1 data from lead program, STX-001, was recently presented at 2025 ASCO Annual Meeting BOSTON–(BUSINESS WIRE)–Strand…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Strand Therapeutics is raising $52,143,967.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jacob Becraft played a…